A newly published case study in the Journal of Dermatology Research has confirmed the clinical efficacy and safety of Mesoheal® Pink Glow, a glutathione-based mesotherapy solution, in the treatment of hyperpigmentation for darker skin types. The peer-reviewed study, conducted by internationally renowned experts Dr. Vincent Wong and Dr. Abdulrahman Abdulbaky, highlights excellent results with no adverse events reported in Fitzpatrick VI skin.

Breakthrough Results
Following just 3 treatment sessions combining pulsed wave RF microneedling (Sylfirm X, PW2 mode, 0.3 mm depth) with topical application of Mesoheal® Pink Glow,
the study reported:

31% decrease in Melanin Index
67% improvement in skin evenness
58% increase in tone uniformity
Zero adverse events, including no post-inflammatory hyperpigmentation (PIH)

Both Investigator and patient Global assessments (IGA and PGA scores) also demonstrated a 50% reduction in hyperpigmentation, underlining the solution’s visible and measurable benefits.

Advancing Inclusive Aesthetics
Hyperpigmentation remains one of the most common and difficult skin concerns, especially for patients with higher melanin content. The confirmation of Mesoheal® Pink Glow's clinical efficacy strengthens its standing as a trusted and scientifically validated solution for global dermatology and aesthetic practices.

Discover the full clinical article in the Journal of Dermatology Research and explore the science behind Mesoheal® Pink Glow.